| 发明名称 |
OFA/ILRP DERIVED MODIFIED PEPTIDE |
| 摘要 |
<p>The present invention relates to a novel modified human oncofoetal antigen immature laminin receptor (OFA/iLR)- derived peptide comprising the sequence VLIENPADV, its stereoisomers, its peptide analogues and mixtures thereof and theiruse for diagnostic and therapeutic purposes, specifically in cancer.</p> |
| 申请公布号 |
WO2011067175(A1) |
申请公布日期 |
2011.06.09 |
| 申请号 |
WO2010EP68280 |
申请日期 |
2010.11.26 |
| 申请人 |
ASKLEPIOS KLINIKEN HAMBURG GMBH;SIEGEL, SANDRA;ZEIS, MATTHIAS |
发明人 |
SIEGEL, SANDRA;ZEIS, MATTHIAS |
| 分类号 |
C07K14/47 |
主分类号 |
C07K14/47 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
